Fanconi Anaemia in South African Patients with Afrikaner Ancestry

Background. Fanconi anaemia (FA) is a rare genetic disorder of impaired DNA repair that results in physical and haematological consequences in affected individuals. In South Africa (SA), individuals with Afrikaner ancestry are at an increased risk of inheriting disease-causing FA mutations, owing to the three common FANCA (FA, complementation group A) founder mutations present in this population subgroup. Objectives . To describe the physical phenotype of SA patients with FANCA mutations for the purpose of recommending appropriate care for affected individuals. Methods . A structured clinical examination and file-based review were used to evaluate the physical phenotype of 7 patients with compound heterozygous and homozygous FANCA founder mutations, and 1 patient with confirmed FANCA complementation analysis. Descriptive statistical analysis was used to determine the frequency of physical anomalies in Afrikaner patients and to compare the described phenotype to other FA cohorts, including a previously clinically characterised black SA FA cohort. Results . An earlier age of diagnosis of FA in Afrikaner patients, a high frequency of somatic anomalies and a higher-than-expected incidence of the VACTERL/H phenotype were noted. Conclusions . Based on our findings, recommendations for the care of FA patients with Afrikaner ancestry are made, including renal ultrasound evaluation at diagnosis and hearing screening

[1]  J. Soulier,et al.  Amendment history : Corrigendum ( March 2017 ) Biallelic inactivation of REV 7 is associated with Fanconi anemia , 2019 .

[2]  A. Jankowska,et al.  Complementation of hypersensitivity to DNA interstrand crosslinking agents demonstrates that XRCC2 is a Fanconi anaemia gene , 2016, Journal of Medical Genetics.

[3]  N. Giri,et al.  Thinking of VACTERL‐H? Rule out Fanconi Anemia according to PHENOS , 2016, American journal of medical genetics. Part A.

[4]  L. Hood,et al.  A novel Fanconi anaemia subtype associated with a dominant-negative mutation in RAD51 , 2015, Nature Communications.

[5]  A. Krause,et al.  Hematological consequences of a FANCG founder mutation in Black South African patients with Fanconi anemia. , 2015, Blood cells, molecules & diseases.

[6]  A. Krause,et al.  Phenotypic consequences in black South African Fanconi anemia patients homozygous for a founder mutation , 2013, Genetics in Medicine.

[7]  A. Figuera,et al.  Origin, functional role, and clinical impact of Fanconi anemia FANCA mutations. , 2011, Blood.

[8]  B. Alter,et al.  Pathophysiology and management of inherited bone marrow failure syndromes. , 2010, Blood reviews.

[9]  C. Mathew,et al.  Should chromosome breakage studies be performed in patients with VACTERL association? , 2005, American journal of medical genetics. Part A.

[10]  C. Lewis,et al.  A common Fanconi anemia mutation in black populations of sub-Saharan Africa. , 2005, Blood.

[11]  S. Batish,et al.  Spectrum of sequence variations in the FANCA gene: An International Fanconi Anemia Registry (IFAR) study , 2003, Human mutation.

[12]  G. Pals,et al.  X-linked inheritance of Fanconi anemia complementation group B , 2004, Nature Genetics.

[13]  T. Nakajima,et al.  Two common founder mutations of the fanconi anemia group g gene FANCG/XRCC9 in the Japanese population , 2003, Human mutation.

[14]  P. Rosenberg,et al.  Cancer incidence in persons with Fanconi anemia. , 2003, Blood.

[15]  C. Mathew,et al.  Molecular and genealogical evidence for a founder effect in Fanconi anemia families of the Afrikaner population of South Africa , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[16]  C. Lewis,et al.  Association of complementation group and mutation type with clinical outcome in fanconi anemia. European Fanconi Anemia Research Group. , 2000, Blood.

[17]  S. Asano,et al.  The IVS4 + 4 A to T mutation of the fanconi anemia gene FANCC is not associated with a severe phenotype in Japanese patients. , 2000, Blood.

[18]  J. Poole,et al.  Comparative study of Fanconi anemia in children of different ethnic origin in South Africa. , 1994, American journal of medical genetics.

[19]  R. Gibson,et al.  A common mutation in the FACC gene causes Fanconi anaemia in Ashkenazi Jews , 1993, Nature Genetics.

[20]  A. Rogatko,et al.  International Fanconi Anemia Registry: relation of clinical symptoms to diepoxybutane sensitivity. , 1989, Blood.

[21]  J. Opitz,et al.  Fanconi anemia: Another disease of unusually high prevalence in the Afrikaans population of South africa , 1987, American journal of medical genetics.